jump to content jump to footer

Software-Assisted Structured Reporting Improves TNM Classification Accuracy in NSCLC Staging

In this multi-center collaboration, thoracic radiology experts developed and evaluated a software-assisted structured reporting (SR) framework for staging non-small cell lung cancer (NSCLC). The study assessed the framework’s effectiveness in enhancing the accuracy of TNM classification and explored institutional standards, preferences, and perceptions of SR among participating institutions.

The software-assisted SR, featuring semi-automated TNM classification of NSCLC in mint Lesion significantly improved classification accuracy compared to traditional free-text reporting (FTR) (p = 0.01). Radiologists using SR were 1.707 times more likely to correctly classify TNM status. The most frequent classification errors were related to T-stage assessment, particularly in tumor size measurement and evaluation of local infiltration. Errors in N- and M-stage classification often resulted from incorrect lesion localization.

"The results of this proof-of-concept study suggest a valuable impact of software-assisted SR on TNM accuracy in NSCLC staging," the authors note.

The tool proved highly reliable, consistently generating accurate TNM classifications based on radiologists’ inputs. This improvement in classification accuracy led to a reduction in both upstaging and downstaging errors.

In a pre- and post-validation survey, participating radiologists expressed generally positive attitudes toward SR for NSCLC staging, rating its potential impact favorably across multiple categories. They acknowledged its value in improving report quality, completeness, and interdisciplinary communication. Positive perceptions of SR increased following hands-on use, indicating that practical experience may enhance its perceived benefits. Additionally, software-assisted SR improved radiologists' understanding of TNM criteria, suggesting these tools may serve as valuable educational aids.

The study also highlights SR's potential to support secondary data use and research. The standardized format of SR can facilitate the creation of large-scale registries, contributing to a deeper understanding of lung cancer trends and treatment outcomes.

The findings underscore the importance of addressing implementation challenges, such as digital infrastructure limitations, to fully realize SR’s potential in routine clinical practice.

This study was conducted as a collaborative effort within the Bavarian Oncologic Radiology Network (BORN) of the Bavarian Cancer Research Center (BZKF). Participating centers included radiology departments from LMU Hospital Munich, Technical University Munich, University Hospital Erlangen, University Hospital Regensburg, University Hospital Würzburg, and University Hospital Augsburg.

 

Read the original publication here.

Heimer, M.M., Dikhtyar, Y., Hoppe, B.F. et al. 2024. ”Software-assisted structured reporting and semi-automated TNM classification for NSCLC staging in a multicenter proof of concept study.” Insights Imaging.

From PCWG3 to PCWG4: Evolving Standards in Prostate Cancer Clinical Trials

The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of…

Read more
Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?

Read more
Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion

Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…

Read more
scroll-top